Financial Ratios Adicon Holdings Limited
Equities
9860
KYG0086A1076
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.500 HKD | +3.77% |
|
+20.80% | +29.08% |
| 06/01 | EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO | AN |
| 14/11 | Adicon Unit to Acquire Crown Bioscience for Up to $204 Million; Shares Fall 8% | MT |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Profitability | |||||
Return on Assets | - | 11.98 | 13.97 | 6.7 | 3.32 |
Return on Total Capital | - | 19.12 | 25.5 | 11.49 | 4.95 |
Return On Equity % | - | 34.07 | 93.49 | 21.49 | 3.47 |
Return on Common Equity | - | 34.51 | 103.54 | 21.17 | 2.8 |
Margin Analysis | |||||
Gross Profit Margin % | 40.73 | 42.68 | 38.98 | 43 | 37.62 |
SG&A Margin | 21.72 | 22.27 | 17.19 | 22.93 | 24.67 |
EBITDA Margin % | 17.48 | 19.09 | 21.02 | 18.53 | 12.29 |
EBITA Margin % | 15.12 | 16.57 | 18.36 | 15.52 | 8.68 |
EBIT Margin % | 15.12 | 16.54 | 18.32 | 15.3 | 8.41 |
Income From Continuing Operations Margin % | 10.56 | 9.54 | 14.09 | 7.95 | 2.15 |
Net Income Margin % | 10.36 | 9.34 | 14.01 | 7.12 | 1.61 |
Net Avail. For Common Margin % | 10.36 | 9.34 | 14.01 | 7.12 | 1.61 |
Normalized Net Income Margin | 8.7 | 9.44 | 10.64 | 6.74 | 4.36 |
Levered Free Cash Flow Margin | - | 14.27 | 12.13 | -13.36 | 8.64 |
Unlevered Free Cash Flow Margin | - | 14.57 | 12.95 | -11.72 | 9.77 |
Asset Turnover | |||||
Asset Turnover | - | 1.16 | 1.22 | 0.7 | 0.63 |
Fixed Assets Turnover | - | 8.85 | 9.4 | 5.53 | 5.01 |
Receivables Turnover (Average Receivables) | - | 3.13 | 3.17 | 1.96 | 2.01 |
Inventory Turnover (Average Inventory) | - | 18.25 | 17.51 | 9.26 | 11.98 |
Short Term Liquidity | |||||
Current Ratio | 2.31 | 1.83 | 1.61 | 1.88 | 1.58 |
Quick Ratio | 2.15 | 1.67 | 1.46 | 1.44 | 1.26 |
Operating Cash Flow to Current Liabilities | 0.48 | 0.41 | 0.37 | 0.21 | 0.12 |
Days Sales Outstanding (Average Receivables) | - | 116.43 | 115.3 | 186.63 | 181.66 |
Days Outstanding Inventory (Average Inventory) | - | 20 | 20.85 | 39.42 | 30.56 |
Average Days Payable Outstanding | - | 92.59 | 98.79 | 186.56 | 151.82 |
Cash Conversion Cycle (Average Days) | - | 43.84 | 37.36 | 39.5 | 60.4 |
Long Term Solvency | |||||
Total Debt/Equity | 79.15 | 110.19 | 319.95 | 59.6 | 84.02 |
Total Debt / Total Capital | 44.18 | 52.42 | 76.19 | 37.34 | 45.66 |
LT Debt/Equity | 64.85 | 100.72 | 293.13 | 51.67 | 54.23 |
Long-Term Debt / Total Capital | 36.2 | 47.92 | 69.8 | 32.37 | 29.47 |
Total Liabilities / Total Assets | 61.85 | 72.58 | 87.39 | 59.84 | 62.12 |
EBIT / Interest Expense | 21.1 | 34.25 | 14.05 | 5.85 | 4.68 |
EBITDA / Interest Expense | 26.86 | 42.64 | 17.06 | 7.77 | 8 |
(EBITDA - Capex) / Interest Expense | 21.46 | 33.15 | 13.46 | 6.04 | 5.81 |
Total Debt / EBITDA | 1.56 | 1.35 | 1.81 | 1.62 | 3.56 |
Net Debt / EBITDA | -0.77 | -0.24 | 0.26 | 0.12 | 1.07 |
Total Debt / (EBITDA - Capex) | 1.95 | 1.74 | 2.3 | 2.09 | 4.9 |
Net Debt / (EBITDA - Capex) | -0.96 | -0.31 | 0.33 | 0.15 | 1.47 |
Growth Over Prior Year | |||||
Total Revenues, 1 Yr. Growth % | - | 23.26 | 43.83 | -32.15 | -11.64 |
Gross Profit, 1 Yr. Growth % | - | 29.17 | 31.36 | -25.15 | -22.69 |
EBITDA, 1 Yr. Growth % | - | 34.56 | 58.42 | -40.21 | -41.42 |
EBITA, 1 Yr. Growth % | - | 35.11 | 59.38 | -42.68 | -50.58 |
EBIT, 1 Yr. Growth % | - | 34.9 | 59.23 | -43.32 | -51.45 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 11.35 | 112.5 | -61.7 | -76.15 |
Net Income, 1 Yr. Growth % | - | 11.06 | 115.75 | -65.5 | -79.98 |
Normalized Net Income, 1 Yr. Growth % | - | 33.84 | 62.03 | -57.01 | -39.22 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | 4.17 | 92 | -67.53 | -79.09 |
Accounts Receivable, 1 Yr. Growth % | - | 28.82 | 53 | -18.4 | -9.11 |
Inventory, 1 Yr. Growth % | - | 6.28 | 109.71 | -23.02 | -28.12 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 35.64 | 35.21 | 0.69 | -5.71 |
Total Assets, 1 Yr. Growth % | - | 14.18 | 56.09 | -6.19 | 2.89 |
Tangible Book Value, 1 Yr. Growth % | - | -25.78 | -62.1 | 414.02 | -4.24 |
Common Equity, 1 Yr. Growth % | - | -21.49 | -36.48 | 234.38 | -3.51 |
Cash From Operations, 1 Yr. Growth % | - | 17.07 | 58.25 | -57.72 | -38.96 |
Capital Expenditures, 1 Yr. Growth % | - | 46.13 | 47.28 | -34.62 | -22.95 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | 22.27 | -174.71 | -157.16 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | 27.78 | -161.44 | -173.6 |
Compound Annual Growth Rate Over Two Years | |||||
Total Revenues, 2 Yr. CAGR % | - | - | 33.15 | -1.22 | -22.57 |
Gross Profit, 2 Yr. CAGR % | - | - | 30.26 | -0.84 | -23.93 |
EBITDA, 2 Yr. CAGR % | - | - | 46.01 | -2.66 | -40.82 |
EBITA, 2 Yr. CAGR % | - | - | 46.74 | -4.4 | -46.77 |
EBIT, 2 Yr. CAGR % | - | - | 46.56 | -5 | -47.54 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | 53.82 | -9.78 | -69.78 |
Net Income, 2 Yr. CAGR % | - | - | 54.79 | -13.72 | -73.72 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 47.26 | -16.54 | -50.44 |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | 41.42 | -21.04 | -73.94 |
Accounts Receivable, 2 Yr. CAGR % | - | - | 40.39 | 11.74 | -13.88 |
Inventory, 2 Yr. CAGR % | - | - | 49.29 | 27.05 | -25.62 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 35.42 | 16.68 | -2.56 |
Total Assets, 2 Yr. CAGR % | - | - | 33.5 | 21.01 | -1.76 |
Tangible Book Value, 2 Yr. CAGR % | - | - | -46.96 | 39.58 | 121.86 |
Common Equity, 2 Yr. CAGR % | - | - | -29.38 | 45.73 | 79.62 |
Cash From Operations, 2 Yr. CAGR % | - | - | 36.11 | -18.2 | -49.2 |
Capital Expenditures, 2 Yr. CAGR % | - | - | 46.7 | -1.87 | -29.02 |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | -4.42 | -34.65 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | -11.4 | -32.75 |
Compound Annual Growth Rate Over Three Years | |||||
Total Revenues, 3 Yr. CAGR % | - | - | - | 6.35 | -4.82 |
Gross Profit, 3 Yr. CAGR % | - | - | - | 8.29 | -8.74 |
EBITDA, 3 Yr. CAGR % | - | - | - | 8.44 | -17.82 |
EBITA, 3 Yr. CAGR % | - | - | - | 7.29 | -23.27 |
EBIT, 3 Yr. CAGR % | - | - | - | 6.78 | -24.04 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | -3.23 | -42.1 |
Net Income, 3 Yr. CAGR % | - | - | - | -6.15 | -46.99 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | -2.31 | -26.44 |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | -13.4 | -49.3 |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | 17.16 | 4.3 |
Inventory, 3 Yr. CAGR % | - | - | - | 19.71 | 5.08 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 22.69 | 8.68 |
Total Assets, 3 Yr. CAGR % | - | - | - | 18.69 | 14.64 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | 13.08 | 23.1 |
Common Equity, 3 Yr. CAGR % | - | - | - | 18.58 | 27.02 |
Cash From Operations, 3 Yr. CAGR % | - | - | - | -7.82 | -25.81 |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | 12.06 | -9.47 |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | -19.47 |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | -16.71 |
- Stock Market
- Equities
- 9860 Stock
- Financials Adicon Holdings Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















